The Federal Trade Commission says more than 100 patents from 10 biopharma companies are improperly listed in the FDA’s official publication of approved products. Such listings delay generic competition, which reduces consumer choice and keeps prices high,
This week in AI news. The post AI Update: The DPA, Faster (But Not Better) Legal Writing, Full AI Contract Negotiation appeared first on Above the Law.
Notes to my (legal) self. The post Picking The Legal Brain Costs Money, You Know… appeared first on Above the Law.
The group of lateral partners from Stroock includes many who held leadership roles. More partners may join Hogan Lovells in the future. The post Hogan Lovells To Welcome Nearly 30 Partners From Stroock, Ahead Of The Firm’s Dissolution appeared first